COVID-19ワクチン開発ツールの世界市場規模は、2028年までに309億USドルに達する見込みです。同市場は、2021年から2028年にかけて8.6%のCAGRで拡大すると予測されています。世界中の研究者たちは、COVID-19の予防接種を開発するための有力な候補を特定し、開発することを急速に説得しています。これは、世界中でSARS-CoV-2の被害が続いていることが原因です。また、SARS-CoV-2の第2波の感染は、北半球の冬の始まりと重なることが予想され、パンデミックの時間軸の中で重要な時期であることが示されました。
そのため、COVID-19の世界的な影響を緩和するためには、有効な予防接種を開発することが必須となります。この必要性を認識して、COVID-19に対する効果的な予防接種の開発に取り組んでいる企業は、4つの主要なワクチン候補、すなわち、mRNA、組換え、不活化、および複製欠損ウイルスベクターに注目しています。これらの4つの候補は重要な分野であり、候補の特性評価のための質量分析とクロマトグラフィーの統合は、上記のすべての候補の開発プロセスに共通しています。
COVID-19ワクチンの標的発見に関しては、スパイクタンパク（S-protein）が最も好ましい標的部位となっています。これは、S-proteinがCOVID-19分子の表面全体に広がっているため、宿主細胞の受容体に付着することができ、ひいてはウイルスが宿主細胞に容易に侵入できることに起因しています。COVID-19ブースターの迅速な開発を目的とした政府の積極的な取り組みにより、この業界で活動する企業にとって有利な環境が整うことが期待されます。
例えば、2020年4月には、COVID-19ブースターの提供と開発を迅速化することを目的とした「COVID-19ツールへのアクセス（ACT）アクセラレータ」が開始されました。この取り組みには、必要なリソースを各国に提供することをサポートするヘルスシステムコネクターが含まれています。これらのツールは、COVAX Facilityという包括的なメカニズムの下でプールされており、COVID-19ワクチン接種・開発ツールの効果的な調達と公平なアクセスを確保しています。ACTアクセラレータは、2021年末までに全世界で約20億回の接種を行うことを目標としています。
目次
Table of Contents
Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 GVR's Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details Of Primary Research
1.5 Information or Data Analysis
1.5.1 COVID-19 Vaccine Development Tools Market: Segment Revenue And Growth Analysis
1.5.1.1 COVID-19 Vaccine Development Tools Market: Segment Definition
1.5.2 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1 Approach 1: Commodity Flow Approach
1.7.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
1.8 Market: CAGR Calculation
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
Chapter 2 Executive Summary
2.1 Competition Milieu
2.2 Segment Outlook
2.3 Market Summary, 2020 (USD Million)
Chapter 3 Covid-19 Vaccine Development Tools Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Parent Market Lineage
3.3 Market Dynamics
3.3.1 Market Drivers Analysis
3.3.1.1 Integral Role Of AI In The COVID-19 Vaccine Race
3.3.1.2 Expanding Pool Of Collaborations To Fast-Track Vaccine Research & Clinical Trials
3.3.1.3 Robust Funding Initiatives Initiated By Government & Private Organizations
3.3.2 Market Restraint Analysis
3.3.2.1 Hesitation Among People Towards Rushed Development Of COVID-19 Vaccine, Hampering Its Effective Uptake
3.3.3 Market Opportunity Analysis
3.3.3.1 Effective Vaccine Coverage Strategies Laid Out By Government Bodies Across The Globe
3.4 Penetration & Growth Prospect Mapping, by Application, 2020
3.5 COVID-19 Vaccine Pipeline Analysis
3.6 Repurposing Vaccines in the Management of COVID-19
3.7 Frontrunners of COVID-19 Vaccines & Their Strategies
Chapter 4 Business Environment Analysis
4.1 SWOT Analysis; by Factor (Political & Legal, Economic and Technological)
4.2 Porter’s Five Forces Analysis
4.3 Vaccine Development Landscape
4.3.1 U.S.
4.3.2 Europe
4.3.3 India
4.3.4 China
4.3.5 Rest Of The World (Row)
4.4 Vaccine Production Analysis, by Volumes, 2020 to 2023
4.4.1 By Region
4.4.1.1 U.S.
4.4.1.2 China
4.4.1.3 Europe
4.4.1.4 Japan
4.4.1.5 Brazil
4.4.2 By Platform
4.4.2.1 Virus
4.4.2.2 Protein
4.4.2.3 Nucleic Acid
4.4.2.4 Viral Vector
4.5 Scaling-up & Distribution of COVID-19 Vaccines: Trend Analysis
Chapter 5 Covid-19 Vaccine Development Tools Market: Technology Business Analysis
5.1 COVID-19 Vaccine Development Tools Market: Technology Movement Analysis
5.2 Laboratory Technologies
5.2.1 COVID-19 Vaccine Development Laboratory Technologies Market Estimates And Forecast, 2020 - 2028 (USD Million)
5.2.2 Next Generation Sequencing
5.2.2.1 COVID-19 Vaccine Development Laboratory Technologies Market Estimates And Forecast, For Next Generation Sequencing, 2020 - 2028 (USD Million)
5.2.3 PCR & qPCR
5.2.3.1 COVID-19 Vaccine Development Laboratory Technologies Market Estimates And Forecast, For PCR & qPCR, 2020 - 2028 (USD Million)
5.2.4 Flow Cytometry
5.2.4.1 COVID-19 Vaccine Development Laboratory Technologies Market Estimates And Forecast, For Flow Cytometry, 2020 - 2028 (USD Million)
5.2.5 Spectrometry
5.2.5.1 COVID-19 Vaccine Development Laboratory Technologies Market Estimates And Forecast, For Spectrometry, 2020 - 2028 (USD Million)
5.2.6 Microscopy/Electron Microscopy
5.2.6.1 COVID-19 Vaccine Development Laboratory Technologies Market Estimates And Forecast For Microscopy/Electron Microscopy, 2020 - 2028 (USD Million)
5.2.7 Preparative & Process Chromatography
5.2.7.1 COVID-19 Vaccine Development Laboratory Technologies Market Estimates And Forecast For Preparative & Process Chromatography, 2020 - 2028 (USD Million)
5.2.8 Nucleic Acid Isolation & Purification
5.2.8.1 COVID-19 Vaccine Development Laboratory Technologies Market Estimates And Forecast For Nucleic Acid Isolation & Purification, 2020 - 2028 (USD Million)
5.2.9 Transfection Electroporation
5.2.9.1 COVID-19 Vaccine Development Laboratory Technologies Market Estimates And Forecast For Transfection Electroporation, 2020 - 2028 (USD Million)
5.2.10 Cell Culture
5.2.10.1 COVID-19 Vaccine Development Laboratory Technologies Market Estimates And Forecast For Cell Culture, 2020 - 2028 (USD Million)
5.2.11 Automated Liquid Handling
5.2.11.1 COVID-19 Vaccine Development Laboratory Technologies Market Estimates And Forecast For Automated Liquid Handling, 2020 - 2028 (USD Million)
5.3 Online Technologies
5.3.1 COVID-19 Vaccine Development Online Technologies Market Estimates And Forecast, 2020 - 2028 (USD Million)
5.3.2 Interactive Web Technologies
5.3.2.1 COVID-19 Vaccine Development Interactive Web Technologies Market Estimates And Forecast, 2020 - 2028 (USD Million)
5.3.3 Vaccine Management & Tracker Technologies
5.3.3.1 COVID-19 Vaccine Development Vaccine Management & Tracker Technologies Market Estimates And Forecast, 2020 - 2028 (USD Million)
Chapter 6 Covid-19 Vaccine Development Tools Market: Application Business Analysis
6.1 COVID-19 Vaccine Development Tools Market: Application Movement Analysis
6.2 Vaccine Research
6.2.1 COVID-19 Vaccine Development Tools Market Estimates And Forecast For Research, 2020 - 2028 (USD Million)
6.3 Vaccine Process Development
6.3.1 COVID-19 Vaccine Development Tools Market Estimates And Forecast For Vaccine Process Development, 2020 - 2028 (USD Million)
6.4 Vaccine Quality Assurance/Quality Control
6.4.1 COVID-19 Vaccine Development Tools Market Estimates And Forecast For Quality Assurance/Quality Control, 2020 - 2028 (USD Million)
Chapter 7 Covid-19 Vaccine Development Tools Market: End-Use Business Analysis
7.1 COVID-19 Vaccine Development Tools Market: End-use Movement Analysis
7.2 Pharma & Biopharma Companies
7.2.1 COVID-19 Vaccine Development Tools Market For Pharma & Biopharma Companies, 2020 - 2028 (USD Million)
7.3 Contract Research Organization (CROs)
7.3.1 COVID-19 Vaccine Development Tools Market For Contract Research Organization (CROs), 2020 - 2028 (USD Million)
7.4 Academic & Research Institutes
7.4.1 COVID-19 Vaccine Development Tools Market For Academic & Research Institutes, 2020 - 2028 (USD Million)
Chapter 8 Regional Business Analysis
8.1 COVID-19 Vaccine Development Tools Market: Regional Movement Analysis
8.2 North America
8.2.1 North America COVID-19 Vaccine Development Tools Market Estimates And Forecast, 2020 - 2028 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Technology 2020 - 2028 (USD Million)
8.2.2.2 U.S. COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Application 2020 - 2028 (USD Million)
8.2.2.3 U.S. COVID-19 Vaccine Development Tools Market Estimates And Forecast, By End Use 2020 - 2028 (USD Million)
8.2.3 Canada
8.2.3.1 Canada COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Technology 2020 - 2028 (USD Million)
8.2.3.2 Canada COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Application 2020 - 2028 (USD Million)
8.2.3.3 Canada COVID-19 Vaccine Development Tools Market Estimates And Forecast, By End Use 2020 - 2028 (USD Million)
8.3 Europe
8.3.1 Europe COVID-19 Vaccine Development Tools Market Estimates And Forecast, 2020 - 2028 (USD Million)
8.3.2 Germany
8.3.2.1 Germany COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Technology 2020 - 2028 (USD Million)
8.3.2.2 Germany COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Application 2020 - 2028 (USD Million)
8.3.2.3 Germany COVID-19 Vaccine Development Tools Market Estimates And Forecast, By End Use 2020 - 2028 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Technology 2020 - 2028 (USD Million)
8.3.3.2 U.K. COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Application 2020 - 2028 (USD Million)
8.3.3.3 U.K. COVID-19 Vaccine Development Tools Market Estimates And Forecast, By End Use 2020 - 2028 (USD Million)
8.3.4 Italy
8.3.4.1 Italy COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Technology 2020 - 2028 (USD Million)
8.3.4.2 Italy COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Application 2020 - 2028 (USD Million)
8.3.4.3 Italy COVID-19 Vaccine Development Tools Market Estimates And Forecast, By End Use 2020 - 2028 (USD Million)
8.3.5 France
8.3.5.1 France COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Technology 2020 - 2028 (USD Million)
8.3.5.2 France COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Application 2020 - 2028 (USD Million)
8.3.5.3 France COVID-19 Vaccine Development Tools Market Estimates And Forecast, By End Use 2020 - 2028 (USD Million)
8.3.6 Spain
8.3.6.1 Spain COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Technology 2020 - 2028 (USD Million)
8.3.6.2 Spain COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Application 2020 - 2028 (USD Million)
8.3.6.3 Spain COVID-19 Vaccine Development Tools Market Estimates And Forecast, By End Use 2020 - 2028 (USD Million)
8.3.7 Russia
8.3.7.1 Russia COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Technology 2020 - 2028 (USD Million)
8.3.7.2 Russia COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Application 2020 - 2028 (USD Million)
8.3.7.3 Russia COVID-19 Vaccine Development Tools Market Estimates And Forecast, By End Use 2020 - 2028 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific COVID-19 Vaccine Development Tools Market Estimates And Forecast, 2020 - 2028 (USD Million)
8.4.2 China
8.4.2.1 China COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Technology 2020 - 2028 (USD Million)
8.4.2.2 China COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Application 2020 - 2028 (USD Million)
8.4.2.3 China COVID-19 Vaccine Development Tools Market Estimates And Forecast, By End Use 2020 - 2028 (USD Million)
8.4.3 India
8.4.3.1 India COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Technology 2020 - 2028 (USD Million)
8.4.3.2 India COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Application 2020 - 2028 (USD Million)
8.4.3.3 India COVID-19 Vaccine Development Tools Market Estimates And Forecast, By End Use 2020 - 2028 (USD Million)
8.4.4 South Korea
8.4.4.1 South Korea COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Technology 2020 - 2028 (USD Million)
8.4.4.2 South Korea COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Application 2020 - 2028 (USD Million)
8.4.4.3 South Korea COVID-19 Vaccine Development Tools Market Estimates And Forecast, By End Use 2020 - 2028 (USD Million)
8.4.5 Australia
8.4.5.1 Australia COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Technology 2020 - 2028 (USD Million)
8.4.5.2 Australia COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Application 2020 - 2028 (USD Million)
8.4.5.3 Australia COVID-19 Vaccine Development Tools Market Estimates And Forecast, By End Use 2020 - 2028 (USD Million)
8.4.6 Japan
8.4.6.1 Japan COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Technology 2020 - 2028 (USD Million)
8.4.6.2 Japan COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Application 2020 - 2028 (USD Million)
8.4.6.3 Japan COVID-19 Vaccine Development Tools Market Estimates And Forecast, By End Use 2020 - 2028 (USD Million)
8.5 Latin America
8.5.1 Latin America COVID-19 Vaccine Development Tools Market Estimates And Forecast, 2020 - 2028 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Technology 2020 - 2028 (USD Million)
8.5.2.2 Brazil COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Application 2020 - 2028 (USD Million)
8.5.2.3 Brazil COVID-19 Vaccine Development Tools Market Estimates And Forecast, By End Use 2020 - 2028 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Technology 2020 - 2028 (USD Million)
8.5.3.2 Mexico COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Application 2020 - 2028 (USD Million)
8.5.3.3 Mexico COVID-19 Vaccine Development Tools Market Estimates And Forecast, By End Use 2020 - 2028 (USD Million)
8.6 Middle East & Africa
8.6.1 Middle East & Africa COVID-19 Vaccine Development Tools Market Estimates And Forecast, 2020 - 2028 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Technology 2020 - 2028 (USD Million)
8.6.2.2 South Africa COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Application 2020 - 2028 (USD Million)
8.6.2.3 South Africa COVID-19 Vaccine Development Tools Market Estimates And Forecast, By End Use 2020 - 2028 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Technology 2020 - 2028 (USD Million)
8.6.3.2 Saudi Arabia COVID-19 Vaccine Development Tools Market Estimates And Forecast, By Application 2020 - 2028 (USD Million)
8.6.3.3 Saudi Arabia COVID-19 Vaccine Development Tools Market Estimates And Forecast, By End Use 2020 - 2028 (USD Million)
Chapter 9 Company Profile
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 Thermo Fisher Scientific, Inc.
9.3.1.1 Company Overview
9.3.1.2 Financial Performance
9.3.1.3 Product Benchmarking
9.3.1.4 Strategic Initiatives
9.3.2 Celerion
9.3.2.1 Company Overview
9.3.2.2 Financial Performance
9.3.2.3 Product Benchmarking
9.3.2.4 Strategic Initiatives
9.3.3 Cole-Parmer Instrument Company, Llc.
9.3.3.1 Company Overview
9.3.3.2 Financial Performance
9.3.3.3 Product Benchmarking
9.3.3.4 Strategic Initiatives
9.3.4 Pfizer
9.3.4.1 Company Overview
9.3.4.2 Financial Performance
9.3.4.3 Product Benchmarking
9.3.4.4 Strategic Initiatives
9.3.5 Sartorius AG
9.3.5.1 Company Overview
9.3.5.2 Financial Performance
9.3.5.3 Product Benchmarking
9.3.5.4 Strategic Initiatives
9.3.6 Stemcell Technologies Inc.
9.3.6.1 Company Overview
9.3.6.2 Financial Performance
9.3.6.3 Product Benchmarking
9.3.6.4 Strategic Initiatives
9.3.7 AB Sciex Pte. Ltd.
9.3.7.1 Company Overview
9.3.7.2 Financial Performance
9.3.7.3 Product Benchmarking
9.3.7.4 Strategic Initiatives
9.3.8 Illumina, Inc.
9.3.8.1 Company Overview
9.3.8.2 Financial Performance
9.3.8.3 Product Benchmarking
9.3.8.4 Strategic Initiatives
9.3.9 Eurofins Scientific
9.3.9.1 Company Overview
9.3.9.2 Financial Performance
9.3.9.3 Product Benchmarking
9.3.9.4 Strategic Initiatives
9.3.10 Agilent Technologies
9.3.10.1 Company Overview
9.3.10.2 Financial Performance
9.3.10.3 Product Benchmarking
9.3.10.4 Strategic Initiatives
9.3.11 Bio-Rad Laboratories, Inc.
9.3.11.1 Company Overview
9.3.11.2 Financial Performance
9.3.11.3 Product Benchmarking
9.3.11.4 Strategic Initiatives
9.3.12 Danaher
9.3.12.1 Company Overview
9.3.12.2 Financial Performance
9.3.12.3 Product Benchmarking
9.3.12.4 Strategic Initiatives
9.3.13 Merck KGaA
9.3.13.1 Company Overview
9.3.13.2 Financial Performance
9.3.13.3 Product Benchmarking
9.3.13.4 Strategic Initiatives
9.3.14 Qiagen N.V.
9.3.14.1 Company Overview
9.3.14.2 Financial Performance
9.3.14.3 Product Benchmarking
9.3.14.4 Strategic Initiatives
9.3.15 Shimadzu Corporation
9.3.15.1 Company Overview
9.3.15.2 Financial Performance
9.3.15.3 Product Benchmarking
9.3.15.4 Strategic Initiatives
